The Netherlands
myTomorrows, founded in 2012, is committed to bridging the gap between patients and untapped treatment prospects with their slogan: "Helping patients discover and access treatments." The company operates a digital platform that simplifies access to clinical trials and expanded access programs, essentially becoming a crucial intermediary for patients and healthcare professionals globally.
The firm has impressively aided over 14,000 patients and 2,200 physicians at more than 200 sites worldwide. Headquartered in multiple global offices, including Amsterdam, New York City, and India, myTomorrows charges BioPharma companies for a suite of services such as logistics management and real-world data collection, enhancing the accessibility and success of clinical initiatives.
Recently, the company secured a $29.00M late-stage VC investment from Avego Bioscience Capital as of 01 November 2025. This capital influx underscores strong investor confidence in their scalable business model and global growth trajectory.
